Subscribe to Newsletter

Geoffrey Guy

Chairman and Founder, GW Pharmaceuticals, Cambridge, UK

Research: Creator of approved cannabinoid medicines Sativex and Epidiolex and leader of innovation and new product discovery at GW Pharmaceuticals. Physician in charge of over 300 clinical studies including first-dose-in-man, pharmacokinetics, pharmacodynamics, dose-ranging, controlled clinical trials and large-scale multi-centered studies and clinical surveys.

Unanswered question: We need a better understanding of homeostasis and the role of the cannabinoids in its modulation; specifically in terms of hormesis, cellular bioenergetics, the microbiome, and neural plasticity.

Part of the Power List

Find out more

Welcome to The Cannabis Scientist Power List 2022!

Go to The Power List 2022

Part of the Power List

Find out more

Celebrating the greatest minds in cannabis science with a high five

Go to The Power List 2021

Part of the Power List

Find out more

Highlighting the Top 20 scientists in two categories: cannabis analysis and cannabis research.

Go to The Power List 2020

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine